Nitric oxide promotes growth and major histocompatibility complex- unrestricted cytotoxicity of interleukin-2-activated rat lymphocytes

Scandinavian Journal of Immunology

Volumn 52, Issue 1, 2000, Pages 62-70

  Badovinac, ^a   Trajkovic, ^b   Mostarica Stojkovic, ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

DIBUTYRYL CYCLIC GMP; FERRICYANIDE; GUANYLATE CYCLASE; INTERLEUKIN 2; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; S NITROSOGLUTATHIONE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GROWTH STIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, SURFACE; CELLS, CULTURED; CYCLIC GMP; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; RATS; RECEPTORS, INTERLEUKIN-2;

EID: 0033947602     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00753.x     Document Type: Article

References (36)

1. 1 Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
2. 2 MacMicking J, Xie Q-W, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
3. 3 Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 1995;7:396-9.
4. 4 Whittington R, Faulds D. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 1993;46:446-514.
5. 5 Filep JG, Baron C, Lachance S, Perreault C, Chan JSD. Involvement of nitric oxide in target-cell lysis and DNA fragmentation induced by murine natural killer cells. Blood 1996;87:5136-43.
6. 6 Cifone MG, D'Alo S, Parroni R et al. Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production. Blood 1999;93:3876-84.
7. 7 Jyothi MD, Khar A. Induction of nitric oxide production by natural killer cells: its role in tumour cell death. Nitric Oxide 1999;3: 409-18.
8. 8 Juretic A, Spagnoli GC, von Bremen K et al. Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent. Cell Immunol 1994;157:462-77.
9. 9 Vujanovic NL, Herberman RB, Hiserodt JC. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Cancer Res 1988;48:878-83.
10. 10 Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
11. 11 Chambers WH, Vujanovic NL, DeLeo AB, Olszow MW, Herberman RB, Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989;169:1373-89.
12. 12 Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science 1990;249:1298-300.
13. 13 Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol 1991;147:3244-50.
14. 14 Bezouska K, Yuen CT, O'Brien J et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994;372:150-7.
15. 15 Cifone MG, Festuccia C, Cironi L et al. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin-2-cultured rat natural killer cells. Cell Immunol 1994;157:181-94.
16. 16 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
17. 17 Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64:313-20.
18. 18 Lipton SA, Choi Y-B, Pan Z-H et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993;364:626-32.
19. 19 Allione A, Bernabei P, Bosticardo M, Ariotti S, Forni G, Novelli F. Nitric oxide suppresses human T lymphocyte proliferation through IFN-γ-dependent and IFN-γ-independent induction of apoptosis. J Immunol 1999;163:4182-91.
20. 20 Hakim TS, Sugimori K, Camporesi EM, Anderson G. Half-life of nitric oxide in aqueous solutions with and without hemoglobin. Physiol Meas 1996;17:267-77.
21. 21 Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994;63:175-95.
22. 22 Theze J, Alzari PM, Bertoglio J. Interleukin-2 and its receptors: recent advances and new immunological functions. Immunol Today 1996;17:481-6.
23. 23 Sciorati C, Rovere P, Ferrarini M, Heltai S, Manfredi AA, Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J Biol Chem 1997;272:23211-5.
24. 24 Dimmeler S, Haendeler J, Sause A, Zeiher AM. Nitric oxide inhibits APO-1/Fas-mediated cell death. Cell Growth Differ 1998;9:415-22.
25. 25 Sun D, Coleclough C, Cao L, Hu X, Sun S, Whitaker JN. Reciprocal stimulation between TNF-α and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis. J Neuroimmunol 1998;89:122-30.
26. 26 Padron J, Glaria L, Martinez O et al. Nitric oxide modulates interleukin-2-induced proliferation in CTLL-2 cells. Med Inflamm 1996;5:324-7.
27. 27 Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signalling pathway. J Immunol 1998;160:5729-34.
28. 28 Tomioka H, Saito H. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J Leukocyte Biol 1992;51:24-31.
29. 29 Maw WW, Shimizu T, Sato K, Tomioka H. Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen-stimulated T-cell proliferation. Clin Exp Immunol 1997;1108:26-33.
30. 30 Furuke K, Burd PR, Horvath-Arcidiacono JA, Hori K, Mostowski H, Bloom ET. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-α. J Immunol 1999;163:1473-80.
31. + subset of rat T cells. J Immunol 1994;152:388-96.
32. + T cells: selective proliferation in interleukin-2, diverse T-cell-receptor-Vβ repertoire and polarized Interferon-γ expression. Immunology 1998;95:117-25.
33. 33 Samlowski WE, Yim CY, McGregor JR. Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis. Nitric Oxide 1998;2:45-56.
34. 34 Park KGM, Hayes PD, Garlick PJ, Sewell H, Eremin O. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 1991;337:645-6.
35. 35 Salvucci O, Kolb JP, Dugas B, Dugas N, Chouaib S. The induction of nitric oxide by interleukin-12 and tumour necrosis factor-α in human natural killer cells: relationship with the regulation of lytic activity. Blood 1998;92:2093-102.
36. 36 Ogawa M, Nishiura T, Yoshimura M et al. Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome. Eur J Clin Invest 1998;28:937-43.